TY - JOUR TI - Development of the DoseProof system for medication monitoring with video confirmation and family support AU - Shvets S.V. AU - Ibragimov R.Z. JO - Pharmaceutical Sciences and Health Products PY - 2026 DA - 2026-09-29 VL - 1 IS - 1 SP - e0002 KW - medication adherence KW - drug therapy KW - mobile applications KW - medication therapy management KW - DoseProof KW - video recording KW - social support AB - Introduction: Suboptimal adherence to long-term pharmacotherapy remains a significant problem, highlighting the need to develop digital tools that support adherence to medication regimens and enable the timely identification of unconfirmed medication-taking events. Aim: To develop and describe the architecture of DoseProof, a medication monitoring system that integrates medication schedules, video confirmation of medication-taking events, and the involvement of a trusted person. Materials and methods: The study followed an applied software system design approach. The methods included a targeted analysis of scientific publications, user scenario modelling, functional requirements decomposition, and client-server architecture design. A scheduled medication-taking event linked to the patient, medication, time, and digital confirmation was defined as the unit of recording. The mobile component was developed for Android using Kotlin and Jetpack Compose; the server-side component was implemented using NestJS and MySQL. Results: An architectural and functional model of the DoseProof prototype was developed, comprising modules for therapy management, notifications, short video storage, identification of unconfirmed events, and interaction with a trusted person. The PENDING, TAKEN, and MISSED event states were formalized, and their transition conditions and measures of digital confirmation completeness were defined. A family monitoring mechanism was proposed whereby the absence of confirmation within a specified time window triggers a notification to the trusted person. The recording of digital confirmation was distinguished from actual medication intake. Conclusion: The DoseProof prototype establishes a unified event-based framework linking therapy schedules, media data, event status, and the mechanism for notifying a trusted person. The system can provide a basis for subsequent evaluation of usability, event-recording reliability, and its impact on medication adherence. The clinical effectiveness of the system and the accuracy of automated biometric verification were not assessed in this study. UR - https://pshp.sciences.kz/article/doseproof-medication-monitoring?lang=en L2 - https://pshp.sciences.kz/downloads/articles/2026/1/1/e0002/en/PSHP_2026_1_1_e0002_EN.pdf ER -